Eltrombopag Powder for Suspension and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Eltrombopag Powder for Suspension and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: eltrombopag
Brand name: Promacta
Synonyms: Eltrombopag
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eltrombopag Powder for Suspension-Insulin degludec
- Eltrombopag Powder for Suspension-Insulin Degludec (U-100) Prefilled Pens
- Eltrombopag Powder for Suspension-Insulin Degludec (U-100) Vials
- Eltrombopag Powder for Suspension-Insulin Degludec (U-200) Prefilled Pens
- Eltrombopag Powder for Suspension-Insulin degludec and liraglutide
- Eltrombopag Powder for Suspension-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Eltrombopag Tablets
- Insulin aspart, recombinant Subcutaneous-Eluxadoline
- Insulin aspart, recombinant Subcutaneous-Elvitegravir
- Insulin aspart, recombinant Subcutaneous-Elvitegravir, cobicistat, emtricitabine, and tenofovir
- Insulin aspart, recombinant Subcutaneous-Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide
- Insulin aspart, recombinant Subcutaneous-Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate